Texas Permanent School Fund Corp Acquires 588 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Texas Permanent School Fund Corp lifted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,452 shares of the company’s stock after purchasing an additional 588 shares during the period. Texas Permanent School Fund Corp’s holdings in Prestige Consumer Healthcare were worth $3,153,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. GAMMA Investing LLC bought a new position in shares of Prestige Consumer Healthcare in the fourth quarter worth about $25,000. Pacer Advisors Inc. raised its stake in Prestige Consumer Healthcare by 85.7% during the 4th quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock worth $27,000 after acquiring an additional 204 shares during the period. Principal Securities Inc. purchased a new position in Prestige Consumer Healthcare during the fourth quarter valued at approximately $29,000. ORG Partners LLC purchased a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth $36,000. Finally, Parallel Advisors LLC increased its stake in shares of Prestige Consumer Healthcare by 42.5% in the fourth quarter. Parallel Advisors LLC now owns 714 shares of the company’s stock worth $44,000 after purchasing an additional 213 shares in the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Price Performance

PBH stock opened at $70.34 on Monday. Prestige Consumer Healthcare Inc. has a one year low of $56.34 and a one year high of $75.31. The company’s fifty day moving average price is $66.74 and its 200-day moving average price is $67.19. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 3.20. The company has a market capitalization of $3.49 billion, a PE ratio of 16.87, a price-to-earnings-growth ratio of 1.99 and a beta of 0.49.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Tuesday, May 14th. The company reported $1.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.12). Prestige Consumer Healthcare had a net margin of 18.60% and a return on equity of 13.48%. The business had revenue of $277.00 million for the quarter, compared to analysts’ expectations of $287.42 million. During the same period in the previous year, the company earned $1.07 EPS. Prestige Consumer Healthcare’s revenue for the quarter was down 3.1% compared to the same quarter last year. On average, equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on PBH shares. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $80.00 target price on shares of Prestige Consumer Healthcare in a report on Tuesday, May 21st. StockNews.com cut Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. Finally, DA Davidson raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $65.00 to $93.00 in a report on Friday, June 21st. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $98.25.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.